Design and rationale of PRAGUE-26: a multicentre, randomised trial of catheter-directed thrombolysis for intermediate-high risk acute pulmonary embolism.
作者信息
Kroupa Josef, Radvan Martin, Mrozek Jan, Sluka Martin, Jirous Stepan, Hlinomaz Ota, Pliva Milan, Pudil Jan, Voberkova Hana, Kozel Martin, Poloczek Martin, Kamenik Martin, Brabec Michal, Lichnerova Eva, Hutyra Martin, Bernat Ivo, Novak Martin, Tousek Petr, Kocka Viktor
机构信息
Department of Cardiology, Third Faculty of Medicine, Charles University, University Hospital Kralovske Vinohrady, Prague, Czech Republic.
Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine of Masaryk University, Brno, Czech Republic.
出版信息
EuroIntervention. 2025 Jun 2;21(11):e642-e648. doi: 10.4244/EIJ-D-24-01085.
Abstract
摘要
相似文献
1
Design and rationale of PRAGUE-26: a multicentre, randomised trial of catheter-directed thrombolysis for intermediate-high risk acute pulmonary embolism.
EuroIntervention. 2025 Jun 2;21(11):e642-e648. doi: 10.4244/EIJ-D-24-01085.
2
Catheter-directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism.
Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD013083. doi: 10.1002/14651858.CD013083.pub2.
3
A meta-analysis of outcomes of catheter-directed thrombolysis for high- and intermediate-risk pulmonary embolism.
J Vasc Surg Venous Lymphat Disord. 2018 Jul;6(4):530-540. doi: 10.1016/j.jvsv.2018.03.010.
4
Comparison of safety and efficacy of ultrasound-accelerated thrombolysis vs. standard catheter-directed thrombolysis for the management of acute pulmonary embolism - a systematic review and meta-analysis.
J Thromb Thrombolysis. 2025 Apr 26. doi: 10.1007/s11239-025-03100-7.
5
Outcomes of catheter-directed embolectomy and surgical embolectomy for intermediate- to high-risk pulmonary embolism: a retrospective observational study.
Curr Med Res Opin. 2025 Apr;41(4):713-720. doi: 10.1080/03007995.2025.2494639. Epub 2025 Apr 28.
6
Barriers to guideline implementation in intermediate- and high-risk Pulmonary Embolism: insights from a real-world cohort study.
Acta Clin Belg. 2025 Jun;80(3):35-43. doi: 10.1080/17843286.2025.2519723. Epub 2025 Jun 16.
7
Thrombolysis for acute deep vein thrombosis.
Cochrane Database Syst Rev. 2016 Nov 10;11(11):CD002783. doi: 10.1002/14651858.CD002783.pub4.
8
Comparison of outcomes and complications in conventional versus ultrasound-accelerated catheter directed thrombolysis for treatment of pulmonary embolism: A systematic review and meta-analysis.
Perfusion. 2023 Sep;38(6):1123-1132. doi: 10.1177/02676591221108811. Epub 2022 Jun 20.
9
Sex-specific disparities in clinical characteristics and outcomes of catheter-directed treatments for acute pulmonary embolism.
Int J Cardiol. 2025 Nov 1;438:133550. doi: 10.1016/j.ijcard.2025.133550. Epub 2025 Jun 23.
10
Catheter-Based Therapies in Acute Pulmonary Embolism-Mortality and Safety Outcomes: A Systematic Review and Meta-Analysis.
J Clin Med. 2025 Jun 12;14(12):4167. doi: 10.3390/jcm14124167.
本文引用的文献
1
PEERLESS II: A Randomized Controlled Trial of Large-Bore Thrombectomy Versus Anticoagulation in Intermediate-Risk Pulmonary Embolism.
J Soc Cardiovasc Angiogr Interv. 2024 May 3;3(6):101982. doi: 10.1016/j.jscai.2024.101982. eCollection 2024 Jun.
2
Catheter Interventions for Pulmonary Embolism: Mechanical Thrombectomy Versus Thrombolytics.
Methodist Debakey Cardiovasc J. 2024 May 16;20(3):36-48. doi: 10.14797/mdcvj.1344. eCollection 2024.
3
Randomized controlled trial of mechanical thrombectomy vs catheter-directed thrombolysis for acute hemodynamically stable pulmonary embolism: Rationale and design of the PEERLESS study.
Am Heart J. 2023 Dec;266:128-137. doi: 10.1016/j.ahj.2023.09.002. Epub 2023 Sep 12.
4
Interventional therapies for pulmonary embolism.
Nat Rev Cardiol. 2023 Oct;20(10):670-684. doi: 10.1038/s41569-023-00876-0. Epub 2023 May 12.
5
Percutaneous treatment options for acute pulmonary embolism: a clinical consensus statement by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function and the European Association of Percutaneous Cardiovascular Interventions.
EuroIntervention. 2022 Oct 7;18(8):e623-e638. doi: 10.4244/EIJ-D-22-00246.
6
A pilot randomised trial of catheter-directed thrombolysis or standard anticoagulation for patients with intermediate-high risk acute pulmonary embolism.
EuroIntervention. 2022 Oct 7;18(8):e639-e646. doi: 10.4244/EIJ-D-21-01080.
7
Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study.
Am Heart J. 2022 Sep;251:43-53. doi: 10.1016/j.ahj.2022.05.011. Epub 2022 May 16.
8
Randomized Trial Comparing Standard Versus Ultrasound-Assisted Thrombolysis for Submassive Pulmonary Embolism: The SUNSET sPE Trial.
JACC Cardiovasc Interv. 2021 Jun 28;14(12):1364-1373. doi: 10.1016/j.jcin.2021.04.049.
9
Hospital volume and outcomes for acute pulmonary embolism: multinational population based cohort study.
BMJ. 2019 Jul 29;366:l4416. doi: 10.1136/bmj.l4416.
10
A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial.
JACC Cardiovasc Interv. 2018 Jul 23;11(14):1401-1410. doi: 10.1016/j.jcin.2018.04.008.
Zotero 插件